Park Avenue Securities LLC Viatris Inc Transaction History

Park Avenue Securities LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 09, 2024	SELL	$10.05 - $12.02 $107,143 - $128,145	-10,661 Reduced 45.73%	12,654 $135,000
Q1 2024 Apr 10, 2024	BUY	$11.27 - $13.53 $20,116 - $24,151	1,785 Added 8.29%	23,315 $278,000
Q4 2023 Jan 10, 2024	BUY	$8.77 - $10.85 $806 - $998	92 Added 0.43%	21,530 $233,000
Q3 2023 Oct 26, 2023	BUY	$9.59 - $11.35 $205,590 - $243,321	21,438 New	21,438 $211,000
Q1 2023 Apr 18, 2023	BUY	$9.2 - $12.26 $252,576 - $336,586	27,454 New	27,454 $264,000

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Park Avenue Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Park Avenue Securities LLC with notifications on news.